Zelira Therapeutics
(OTC) ZLDAF
Zelira Therapeutics Financials at a Glance
Market Cap
$4.96M
Revenue (TTM)
$95.61K
Net Income (TTM)
$40.20M
EPS (TTM)
$-0.21
P/E Ratio
-2.02
Dividend
$0.00
Beta (Volatility)
2.53 (High)
Dividend
$0.00
Beta (Volatility)
2.53 (High)
Price
$0.42
Volume
1
Open
$0.42
Price
$0.42
Volume
1
Open
$0.42
Previous Close
$0.42
Daily Range
$0.42 - $0.42
52-Week Range
$0.20 - $0.42
Dividend
$0.00
Beta (Volatility)
2.53 (High)
Price
$0.42
Volume
1
Open
$0.42
Previous Close
$0.42
Daily Range
$0.42 - $0.42
52-Week Range
$0.20 - $0.42
ZLDAF News
ZLDAF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zelira Therapeutics
Industry
Pharmaceuticals
Sector
Health CareCEO
Oludare Odumosu, PhD
Website
zeliratx.comHeadquarters
Perth, WA 6000, AU
ZLDAF Financials
Key Financial Metrics (TTM)
Gross Margin
-1226%
Operating Margin
-6638%
Net Income Margin
-5539%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-3%
Earnings Yield
-49.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.96M
Shares Outstanding
11.90M
Volume
1
Short Interest
0.00%
Avg. Volume
27.541
Financials (TTM)
Gross Profit
$802.95K
Operating Income
$3.95M
EBITDA
$4.05M
Operating Cash Flow
$4.91M
Capital Expenditure
$0.00
Free Cash Flow
$4.91M
Cash & ST Invst.
$5.66K
Total Debt
$2.14M
Zelira Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$800.84K
+32.3%
Gross Margin
0.00%
N/A
Market Cap
$4.96M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.22M
+47.0%
EBITDA
$2.68M
+22.0%
Quarterly Fundamentals
Net Cash
$2.14M
-632.2%
Accounts Receivable
$4.69K
+529.2%
Inventory
$477.91K
-68.7%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.14M
+1402.5%
Return on Assets
-2.79%
N/A
Return on Invested Capital
1.01%
N/A
Free Cash Flow
$2.27M
+37.6%
Operating Cash Flow
$2.27M
+37.6%